Wednesday, November 25, 2009, 9:19am EST - Canadian Markets open in 11 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

ev3, Inc. (EVVV)

 On Nov 24: 12.95 USD   0.00 (0.00%)  
MORE ON EVVV
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
ev3 Inc. (NasdaqNM:EVVV) Delayed quote dataEdit
Last Trade: 12.95 USD
Trade Time: Nov 24
Change: 0.00 (0.00%)
Prev Close: 12.95
Open: N/A
Bid: 12.50 x 2000
Ask: 13.52 x 100
1y Target Est: 14.40
Day's Range: N/A - N/A
52wk Range: 4.22 - 13.39
Volume: 0
Avg Vol (3m): 983,691
Market Cap: 1.45B
P/E (ttm): N/A
EPS (ttm): -2.46
Div & Yield: N/A (N/A%)
ev3, Inc. (EVVV)
1d  5d  3m  6m  1y  2y  5y 
Free Annual Reports
 Add EVVV to Portfolio   Download Data

HEADLINES
• Piper Jaffray Award Winning Analyst Says Health Care Reform Equity Valuation Fears Have Passed: Stock Picks For Q4 2009
Wall Street Transcript (Tue, Nov 10)
• EV3 INC. Financials
EDGAR Online Financials (Fri, Nov 6)
• EV3 INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 3)
• Spo Advisory Buys $9.5M Worth of Resolute Energy
TheStreet.com (Fri, Oct 30)
• ev3 Beats Zacks Estimate
Zacks.com (Wed, Oct 28)
• ev3, Inc. Q3 2009 Earnings Call Transcript
at Seeking Alpha (Tue, Oct 27)
• UPDATE - Ev3 Q3 results above estimates, raises FY view
at Reuters (Tue, Oct 27)
• HEADLINE STOCKS-U.S. small/midcap stocks to watch on Oct 27
at Reuters (Tue, Oct 27)
• ev3 Inc. Earnings Call scheduled for 8:30 am ET today
CCBN (Tue, Oct 27)
• Q3 2009 ev3 Inc. Earnings Release - Before Market Open
CCBN (Tue, Oct 27)
• EV3 INC. Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Tue, Oct 27)
More Headlines for EVVV...
ANALYST
EPS Est (next year) (Dec-09) : 0.23
EPS Est (in 2 years) (Dec-10) : 0.47
Avg Rec (current)*: 2.4
PEG Ratio: 1.98
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
ev3 Inc. operates as an endovascular company that focuses on identifying and treating peripheral vascular disease, including lower extremity arterial disease and neurovascular disease.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices